ProMetic in development accord with Abraxis
January 5, 2010 by leonardzehr · Leave a Comment
ProMetic Life Sciences (TSX:PLI) and Abraxis BioScience (NASDAQ: ABII) of Los Angeles have entered into a collaboration agreement to develop and commercialize various applications using ProMetic’s prion capture technology platform to improve the safety profile of blood-derived therapeutics. Under the accord, both companies will equally share the cost for the development of new applications as well [...]
Listen to BioTuesdays 
